Terje Kalland

Directeur/Membre du Conseil chez Accuro Immunology AB

Profil

Terje Kalland is currently a Director at Accuro Immunology AB, Akinion Pharmaceuticals AB, Arts Biologics A, and a Member of the Royal Swedish Academy of Engineering Sciences.
Previously, he held positions such as Chief Executive Officer at Karolinska Development AB (Private Equity), Deputy CEO & Chief Scientific Officer at Karolinska Development AB, Chairman at KDev Oncology AB, Director at Dako Denmark ApS, Director at CBio Ltd., Director at KDev Exploratory AB, Deputy Director at Aprea Therapeutics AB, Director at Axelar AB, Director at ClanoTech AB, Director at Modus Therapeutics AB, Senior Vice President-Biopharmaceuticals Research at Novo Nordisk A, Head-Research & Development at Biovitrum AB, Head-Global Oncology Research at Pharmacia Corp., Member-Supervisory Board at Innate Pharma SA, and Professor at the University of Lund.
His current jobs include Director positions at Accuro Immunology AB, Akinion Pharmaceuticals AB, Arts Biologics A, and membership in the Royal Swedish Academy of Engineering Sciences.

Postes actifs de Terje Kalland

Sociétés	Poste	Début
Accuro Immunology AB	Directeur/Membre du Conseil	-
Royal Swedish Academy of Engineering Sciences	Corporate Officer/Principal	21/04/2011
Arts Biologics A/S	Directeur/Membre du Conseil	-
Akinion Pharmaceuticals AB	Directeur/Membre du Conseil	-

Anciens postes connus de Terje Kalland

Sociétés	Poste	Fin
SYNACT PHARMA AB	Directeur/Membre du Conseil	20/03/2024
Karolinska Development AB (Private Equity)	Directeur Général	31/12/2015
KDVENTURES AB	Directeur Technique/Scientifique/R&D	31/12/2015
CBio Ltd.	Directeur/Membre du Conseil	28/12/2011
NOVO NORDISK A/S	Corporate Officer/Principal	01/01/2011